IDSA GUIDELINES Bundle (free trial)

Fever and Neutropenia

IDSA GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/53994

Contents of this Issue

Navigation

Page 12 of 15

Figure 1. Initial Management of Fever and Neutropenia Fever (≥ 38.3ºC) and Neutropenia (≤ 0.5 x 109 Low Risk > Anticipated profound neutropenia (≤ 100 cells/mm3 ) ≤ 7 days AND > Clinically stable AND > No medical comorbidities Outpatient Antibiotics > Oral regimen if able to tolerate and absorb > Availability of caregiver, telephone, transportation > Patient & physician decision Inpatient IV Antibiotics > Documented infection requiring IV antibiotics > Gastrointestinal intolerance > Patient & physician decision Oral ciprofloxacin + amoxicillin/ clavuanate If responding and criteria met for outpatient management (see text) Observe 4-24 h in clinic to ensure that empiric antibiotics are tolerated and patient remains stable prior to discharge for outpatient therapy Adjust antimicrobials based on specific clinical, radiograph and/or culture data, for example: > For cellulitis or pneumonia: vancomycin or linezolid > For pneumonia or gram negative bacteremia: add aminoglycoside and switch to carbapenem > For abdominal symptoms or suspected C. difficile infection: metronidazole /L) High Risk > Anticipated profound neutropenia (≤ 100 cells/mm3 ) > 7 days OR > Clinically unstable OR > Any medical comorbidies Inpatient IV Antibiotics Empiric antibiotic monotherapy (any of the following): > Piperacillin/tazobactam OR > Carbapenem OR > Ceftazidime OR > Cefepime 11

Articles in this issue

Archives of this issue

view archives of IDSA GUIDELINES Bundle (free trial) - Fever and Neutropenia